Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers

Background/Aims : Primary biliary cirrhosis (PBC) is an autoimmune disease of the liver with inflammation of small and middle-sized bile ducts. Serum lipids are frequently elevated, but the use of a lipid lowering drug therapy in PBC is still a matter of debate. Application of an inhibitor of 3-hydr...

Ausführliche Beschreibung